British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
David L. Smith, Ingrid Du Rand, C. Addy, Timothy Collyns, Simon P. Hart, Philip Mitchelmore, Najib M. Rahman, Ravijyot Saggu
Abstract
Table 1 Summary of outcome measures population intervention Control outcomes Adults with asthma Long-term, lowdose macrolides Placebo Quality-of-life measures Symptom improvement/symptom score Exacerbation rates Hospital admission rate Disease progression and changes in lung function tests Mortality Exercise capacity/tolerance Sputum volume/colour/character and microbiological resistance/dysbiosis Drug monitoring/side effects/toxicity Adults with bronchiectasis Adults with COPD Adults with bronchiolitis obliterans Adults with chronic cough Adults with organising pneumonia Adults with diffuse panbronchiolitis
Topics & Concepts
MedicineBronchiolitis obliteransBronchiectasisPneumoniaExacerbationAsthmaQuality of life (healthcare)PopulationPulmonary function testingCOPDIntensive care medicineInternal medicinePhysical therapyLungNursingEnvironmental healthLung transplantationRespiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseases